ES2316968T3 - Nuevos derivados de aminopiridina utilizados como antagonistas de mglur5. - Google Patents

Nuevos derivados de aminopiridina utilizados como antagonistas de mglur5. Download PDF

Info

Publication number
ES2316968T3
ES2316968T3 ES04717193T ES04717193T ES2316968T3 ES 2316968 T3 ES2316968 T3 ES 2316968T3 ES 04717193 T ES04717193 T ES 04717193T ES 04717193 T ES04717193 T ES 04717193T ES 2316968 T3 ES2316968 T3 ES 2316968T3
Authority
ES
Spain
Prior art keywords
pyridin
amine
methyl
phenylethynyl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04717193T
Other languages
English (en)
Spanish (es)
Inventor
Christelle Bolea
Vincent Mutel
Jean-Philippe Rocher
Anne-Sophie Bessis
Emmanuel Le Poul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Addex Pharmaceuticals SA
Original Assignee
Addex Pharmaceuticals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0304901A external-priority patent/GB0304901D0/en
Priority claimed from GB0316430A external-priority patent/GB0316430D0/en
Application filed by Addex Pharmaceuticals SA filed Critical Addex Pharmaceuticals SA
Application granted granted Critical
Publication of ES2316968T3 publication Critical patent/ES2316968T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES04717193T 2003-03-04 2004-03-04 Nuevos derivados de aminopiridina utilizados como antagonistas de mglur5. Expired - Lifetime ES2316968T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0304901A GB0304901D0 (en) 2003-03-04 2003-03-04 Novel aminopyridine derivatives as mGIuR5 antagonists
GB0304901 2003-03-04
GB0316430 2003-07-14
GB0316430A GB0316430D0 (en) 2003-07-14 2003-07-14 Aminopyridine derivatives

Publications (1)

Publication Number Publication Date
ES2316968T3 true ES2316968T3 (es) 2009-04-16

Family

ID=32964064

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04717193T Expired - Lifetime ES2316968T3 (es) 2003-03-04 2004-03-04 Nuevos derivados de aminopiridina utilizados como antagonistas de mglur5.

Country Status (16)

Country Link
US (2) US7205411B2 (cg-RX-API-DMAC7.html)
EP (2) EP2028180A1 (cg-RX-API-DMAC7.html)
JP (1) JP2006519251A (cg-RX-API-DMAC7.html)
AT (1) ATE415390T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004218180B2 (cg-RX-API-DMAC7.html)
CA (1) CA2517083A1 (cg-RX-API-DMAC7.html)
CY (1) CY1108837T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004017966D1 (cg-RX-API-DMAC7.html)
DK (1) DK1603877T3 (cg-RX-API-DMAC7.html)
ES (1) ES2316968T3 (cg-RX-API-DMAC7.html)
PL (1) PL1603877T3 (cg-RX-API-DMAC7.html)
PT (1) PT1603877E (cg-RX-API-DMAC7.html)
RU (1) RU2330020C2 (cg-RX-API-DMAC7.html)
SI (1) SI1603877T1 (cg-RX-API-DMAC7.html)
UA (1) UA81464C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004078728A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0413605D0 (en) 2004-06-17 2004-07-21 Addex Pharmaceuticals Sa Novel compounds
AU2006240217A1 (en) * 2005-04-22 2006-11-02 Merck & Co., Inc. Phenyl ethyne compounds
WO2007035823A2 (en) * 2005-09-20 2007-03-29 Molecular Neuroimaging, Llc Partial mglur5 antagonists and methods of use thereof
DE102005062987A1 (de) * 2005-12-28 2007-07-05 Grünenthal GmbH Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
EP2272509A1 (en) * 2006-09-11 2011-01-12 Novartis AG New Uses of metabotropic glutamate receptors
EA201391348A8 (ru) 2011-03-18 2014-11-28 Новартис Аг КОМБИНАЦИИ АКТИВАТОРОВ АЛЬФА-7 НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА И АНТАГОНИСТОВ mGluR5, ПРЕДНАЗНАЧЕННЫЕ ДЛЯ ПРИМЕНЕНИЯ ПРИ ВЫЗВАННОЙ ДОПАМИНОМ ДИСКИНЕЗИИ, СВЯЗАННОЙ С БОЛЕЗНЬЮ ПАРКИНСОНА

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6028963A (ja) * 1983-07-27 1985-02-14 Takeda Chem Ind Ltd 置換ビニル誘導体
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
DE10009000A1 (de) 2000-02-25 2001-08-30 Basf Ag Verfahren zur Herstellung substituierter Indole
NZ525917A (en) 2000-12-04 2005-11-25 F Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists and their use in treating mGLuR5 receptor mediated disorders

Also Published As

Publication number Publication date
AU2004218180B2 (en) 2009-11-12
EP1603877A1 (en) 2005-12-14
DK1603877T3 (da) 2009-03-09
RU2330020C2 (ru) 2008-07-27
US20080004316A1 (en) 2008-01-03
PT1603877E (pt) 2009-02-11
EP2028180A1 (en) 2009-02-25
RU2005130647A (ru) 2006-04-10
US20060030601A1 (en) 2006-02-09
UA81464C2 (en) 2008-01-10
CA2517083A1 (en) 2004-09-16
ATE415390T1 (de) 2008-12-15
AU2004218180A1 (en) 2004-09-16
PL1603877T3 (pl) 2009-05-29
EP1603877B1 (en) 2008-11-26
SI1603877T1 (sl) 2009-04-30
WO2004078728A1 (en) 2004-09-16
DE602004017966D1 (de) 2009-01-08
CY1108837T1 (el) 2014-07-02
US7205411B2 (en) 2007-04-17
JP2006519251A (ja) 2006-08-24

Similar Documents

Publication Publication Date Title
ES2404034T3 (es) Derivados de alquinilo como moduladores de receptores metabotrópicos de glutamato
JP2989667B2 (ja) 5−HT▲下1▼▲下a▼拮抗物質及び5−HT▲下2▼ 拮抗物質としてのベンゾイミダゾロン誘導体
JP2006509832A (ja) サイクリックヌクレオチドホスホジエステラーゼ阻害剤、その調製及び使用
JP2004508357A (ja) キノリンおよびキナゾリン誘導体
CZ293863B6 (cs) @Fenylpyridin@ylaminové derivátyŹ jejich použití a farmaceutické kompozice na jejich bázi
KR100742013B1 (ko) 4-아릴-니코틴아마이드 유도체의 제조 방법
KR20060123208A (ko) 피라진 유도체 및 이의 약학적 용도
OA11089A (en) Atropisomers of 3-aryl-4(3H)-quinazolinones and their use as ampa-receptor antagonists
Binder et al. Analogs and derivatives of tenoxicam. 1. Synthesis and antiinflammatory activities of analogs with different residues on the ring nitrogen and the amide nitrogen
EP3144303B1 (en) 6-substituted phenoxychroman carboxylic acid derivatives
JP2011511046A (ja) 5,6−ビスアリール−2−ピリジン−カルボキシアミド誘導体、この調製、およびウロテンシンii受容体の拮抗剤としてのこの治療的用途
JP5002592B2 (ja) うつ病およびストレス疾患のためのアジノンおよびジアジノンv3阻害剤
Kim et al. Novel N-biphenyl-2-ylmethyl 2-methoxyphenylpiperazinylalkanamides as 5-HT7R antagonists for the treatment of depression
US20080004316A1 (en) Novel aminopyridine derivatives as mGluR5 antagonists
RU2188197C2 (ru) 1,4-дизамещенные пиперазины, способ их получения, фармацевтическая композиция и способ лечения нейрогенного воспаления
OA11088A (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
KR860000104B1 (ko) 2-피리딘 카복스아미드 유도체의 제조방법
CN100528872C (zh) 一类四氢原小檗碱类化合物、其制备方法及其组合物和用途
AU2006212192B2 (en) Non steroidal glucocorticoid receptor modulators
US3694450A (en) 2-substituted-4,5,6,7-tetrahydrobenzothiazole-4-carboxylic acids and their alkyl esters
JPS6156180A (ja) イミダゾ複素環化合物
CN103664804B (zh) 吡考他胺类似物、制备方法及其应用
HK1128918A (en) Novel aminopyridine derivatives as mglur5 antagonists
TW201315731A (zh) 菸鹼乙醯膽鹼受體之新穎正向異位調節劑
Hu et al. An efficient synthesis of Erismodegib